14-1190b-innovation-managing-risk-evidence
14-1190b-innovation-managing-risk-evidence
14-1190b-innovation-managing-risk-evidence
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
38<br />
CASE STUDY<br />
CONSISTENCY AND TRANSPARENCY IN EVIDENCE-BASED<br />
REGULATION: RISK AND PRECAUTION IN THE REGULATION<br />
OF BISPHENOL A<br />
Patrick Miller (Food Standards Agency)<br />
Regulators often need to review and adapt<br />
regulations as the <strong>evidence</strong> on <strong>risk</strong>s develops.<br />
But if they are to maintain credibility and<br />
trust, they must handle this process in a consistent<br />
and transparent way, and always explain the rationale<br />
for their <strong>risk</strong>-management decisions. They should<br />
clearly distinguish between hazard and <strong>risk</strong>; between<br />
the uncertainties addressed directly within a <strong>risk</strong><br />
assessment, and wider uncertainties that may pertain<br />
to the <strong>risk</strong> management decision; and consider the<br />
unintended consequences of any new measures. The<br />
case of bisphenol A (BPA) illustrates some of the<br />
challenges of this approach.<br />
BPA is a chemical used to make plastics, including<br />
those used as protective coatings and linings for food<br />
and drinks cans, and also in some refillable<br />
drinks bottles and food storage containers.<br />
Minute amounts of BPA can transfer<br />
from these materials into food and<br />
drinks. For plastic food-contact<br />
materials, EU legislation sets limits for<br />
the amount of BPA that can migrate<br />
into food. These ensure consumer<br />
exposure remains within guidelines<br />
established by independent expert <strong>risk</strong><br />
assessments.<br />
There is some <strong>evidence</strong> that BPA interacts<br />
with hormone systems and may act as an endocrine<br />
disruptor. Consequently its safety has been reviewed<br />
several times to assess whether these potential effects<br />
are relevant for human exposure to BPA. The European<br />
Food Safety Authority (EFSA) began its most recent<br />
comprehensive review of BPA in 2012, and consulted<br />
on two parts of its draft opinion in 2013 and 20<strong>14</strong>;<br />
its final opinion is due later in 20<strong>14</strong>. The draft EFSA<br />
opinion proposes a revised exposure guideline for<br />
BPA and concludes that exposures to BPA are below<br />
this level for consumers in all age groups. EFSA’s<br />
initial finding is thus that the health concern for all<br />
population groups is low 1 .<br />
rigorous assessment of the balance of <strong>evidence</strong>,<br />
and an understanding of how any changes will<br />
achieve an improvement in consumer protection in<br />
a proportionate way, while guarding against adverse<br />
unintended consequences. The UK Committee on<br />
Toxicity of Chemicals in Food, Consumer Products<br />
and the Environment (COT) has concluded that the<br />
draft EFSA opinion does not indicate a <strong>risk</strong> to UK<br />
consumers from dietary exposure to BPA 2 . The FSA<br />
will also assess the final EFSA opinion and review the<br />
need for any further action, working with the European<br />
Commission and EU member states 3 .<br />
Some EU member states have already introduced or<br />
announced plans for more restrictive controls on BPA,<br />
which are described as ‘precautionary’. This raises a<br />
number of issues:<br />
1. Acting in advance of, or contrary to,<br />
an EFSA opinion <strong>risk</strong>s undermining<br />
the process of <strong>risk</strong>-based decision<br />
making in the European Union.<br />
2. According a communication<br />
from the European Commission, the<br />
‘precautionary principle’ should not be<br />
used to cope with uncertainties that<br />
are dealt with during a <strong>risk</strong> assessment,<br />
but only when there are wider, more<br />
fundamental <strong>evidence</strong> gaps 4 .<br />
3. Use of precaution should not be one-sided.<br />
Regulators need to consider the balance of <strong>risk</strong>s and<br />
benefits, and the associated uncertainties, that are<br />
caused by a ‘precautionary’ action, and compare that<br />
with the effects of maintaining the status quo. This<br />
includes a consideration of unintended consequences<br />
— for example, problems with the safety and<br />
effectiveness of replacements for BPA.<br />
4. Decision-makers may of course take other factors<br />
into account, and do not have to rely solely on the<br />
<strong>risk</strong> assessment — but when they do so, they should<br />
set out their rationale and the supporting <strong>evidence</strong><br />
transparently.<br />
Regulatory responses to the revised EFSA <strong>risk</strong><br />
assessment<br />
The UK Food Standards Agency (FSA) is clear that<br />
any change in BPA controls should be based on a<br />
The FSA is working with the network of national food<br />
agencies in Europe to try to develop principles and<br />
tools to improve consistency and transparency in this<br />
process 5 .